237 related articles for article (PubMed ID: 8809221)
21. Mechanism-based inactivation of human cytochrome P450 3A4 by grapefruit juice and red wine.
Chan WK; Nguyen LT; Miller VP; Harris RZ
Life Sci; 1998; 62(10):PL135-42. PubMed ID: 9496718
[TBL] [Abstract][Full Text] [Related]
22. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity.
Guo LQ; Fukuda K; Ohta T; Yamazoe Y
Drug Metab Dispos; 2000 Jul; 28(7):766-71. PubMed ID: 10859150
[TBL] [Abstract][Full Text] [Related]
23. Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice.
Erlund I; Meririnne E; Alfthan G; Aro A
J Nutr; 2001 Feb; 131(2):235-41. PubMed ID: 11160539
[TBL] [Abstract][Full Text] [Related]
24. Variation of flavonoids and furanocoumarins in grapefruit juices: a potential source of variability in grapefruit juice-drug interaction studies.
De Castro WV; Mertens-Talcott S; Rubner A; Butterweck V; Derendorf H
J Agric Food Chem; 2006 Jan; 54(1):249-55. PubMed ID: 16390207
[TBL] [Abstract][Full Text] [Related]
25. Grapefruit juice--felodipine interaction: mechanism, predictability, and effect of naringin.
Bailey DG; Arnold JM; Munoz C; Spence JD
Clin Pharmacol Ther; 1993 Jun; 53(6):637-42. PubMed ID: 8513655
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components.
Eagling VA; Profit L; Back DJ
Br J Clin Pharmacol; 1999 Oct; 48(4):543-52. PubMed ID: 10583025
[TBL] [Abstract][Full Text] [Related]
27. [Flavonoids--bioactive compounds in fruits juice].
Harapu CD; Miron A; Cuciureanu M; Cuciureanu R
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1209-14. PubMed ID: 21500482
[TBL] [Abstract][Full Text] [Related]
28. Construction of a model to estimate the CYP3A inhibitory effect of grapefruit juice.
Uesawa Y; Abe M; Fukuda E; Baba M; Okada Y; Mohri K
Pharmazie; 2011 Jul; 66(7):525-8. PubMed ID: 21812328
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice.
Miniscalco A; Lundahl J; Regårdh CG; Edgar B; Eriksson UG
J Pharmacol Exp Ther; 1992 Jun; 261(3):1195-9. PubMed ID: 1602384
[TBL] [Abstract][Full Text] [Related]
30. In vitro effects of the citrus flavonoids diosmin, naringenin and naringin on the hepatic drug-metabolizing CYP3A enzyme in human, pig, mouse and fish.
Burkina V; Zlabek V; Halsne R; Ropstad E; Zamaratskaia G
Biochem Pharmacol; 2016 Jun; 110-111():109-16. PubMed ID: 27107807
[TBL] [Abstract][Full Text] [Related]
31. In vitro inhibition of midazolam and quinidine metabolism by flavonoids.
Ha HR; Chen J; Leuenberger PM; Freiburghaus AU; Follath F
Eur J Clin Pharmacol; 1995; 48(5):367-71. PubMed ID: 8641324
[TBL] [Abstract][Full Text] [Related]
32. In vitro inhibition of simvastatin metabolism in rat and human liver by naringenin.
Ubeaud G; Hagenbach J; Vandenschrieck S; Jung L; Koffel JC
Life Sci; 1999; 65(13):1403-12. PubMed ID: 10503959
[TBL] [Abstract][Full Text] [Related]
33. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics.
Bailey DG; Arnold JM; Strong HA; Munoz C; Spence JD
Clin Pharmacol Ther; 1993 Dec; 54(6):589-94. PubMed ID: 8275614
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins.
Schmiedlin-Ren P; Edwards DJ; Fitzsimmons ME; He K; Lown KS; Woster PM; Rahman A; Thummel KE; Fisher JM; Hollenberg PF; Watkins PB
Drug Metab Dispos; 1997 Nov; 25(11):1228-33. PubMed ID: 9351897
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo.
Dresser GK; Wacher V; Wong S; Wong HT; Bailey DG
Clin Pharmacol Ther; 2002 Sep; 72(3):247-55. PubMed ID: 12235445
[TBL] [Abstract][Full Text] [Related]
36. The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein.
Di Marco MP; Edwards DJ; Wainer IW; Ducharme MP
Life Sci; 2002 Jul; 71(10):1149-60. PubMed ID: 12095536
[TBL] [Abstract][Full Text] [Related]
37. Effect of grapefruit juice, naringin, naringenin, and bergamottin on the intestinal carrier-mediated transport of talinolol in rats.
de Castro WV; Mertens-Talcott S; Derendorf H; Butterweck V
J Agric Food Chem; 2008 Jun; 56(12):4840-5. PubMed ID: 18494494
[TBL] [Abstract][Full Text] [Related]
38. Variations in content of active ingredients causing drug interactions in grapefruit juice products sold in California.
Wanwimolruk S; Marquez PV
Drug Metabol Drug Interact; 2006; 21(3-4):233-43. PubMed ID: 16841515
[TBL] [Abstract][Full Text] [Related]
39. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice.
Bailey DG; Dresser GK; Bend JR
Clin Pharmacol Ther; 2003 Jun; 73(6):529-37. PubMed ID: 12811362
[TBL] [Abstract][Full Text] [Related]
40. Taste responses to naringin, a flavonoid, and the acceptance of grapefruit juice are related to genetic sensitivity to 6-n-propylthiouracil.
Drewnowski A; Henderson SA; Shore AB
Am J Clin Nutr; 1997 Aug; 66(2):391-7. PubMed ID: 9250119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
